姓名:王帅玉
性别:男
职称:副教授
学位:博士
所在系:临床兽医系
导师类型:硕士生导师
出生年月:1981.12
电子邮件:12-12sy@163.com
个人简介
个人简介:
2012年博士毕业于韩国科学院大学,2016年7月至今,任职于中国农业大学动物医学院临床兽医学系中兽医学教研室,从事教学、小动物临床及中兽医药学科研工作。主要研究方向:血管生成、免疫调节和中兽药新药开发。在Marine Drugs、Journal of Functional Foods等杂志以第一作者发表多篇论文。
代表性文章:
1.Shuaiyu Wang, Li-Jun Wang, Bo Jiang, Ning Wu, Xiang-Qian Li, Jiao Luo, Bao-Cheng Wang, Ren-Shuai Zhang, Qi Xu and Da-Yong Shi. Synthesis and biological evaluation of novel fluorinated anticancer agents incorporating the indolin-2-one moiety. RSC Advances. 2015.10. DOI: 10.1039/c5ra19617e.
2.Shuaiyu Wang, Li-Jun Wang, Bo Jiang, Ning Wu, Xiangqian Li, Shaofang Liu, Jiao Luo and Dayong Shi. Anti-Angiogenic Properties of BDDPM, a Bromophenol from Marine Red Alga Rhodomela confervoides, with Multi Receptor Tyrosine Kinase Inhibition Effects. Int. J. Mol. Sci. 2015, 16, 13548-13560; doi:10.3390/ijms160613548.
3.Li-Jun Wang, Shuaiyu Wang, Bo Jiang, Ning Wu, Bao-Cheng Wang, Meng Yang, Shui-Hua Jin, and Da-Yong Shi. Design, synthesis and biological evaluation of novel indolin-2-one derivatives incorporating bromophenol moiety as potential anticancer agents. Marine drugs. 2015. 01. (共同第一作者).
4.Shuaiyu Wang, Yeo Cho Yoon, Mi-Jeong Sung, Jin-Taek Hwang, Haeng-Jeon Hur, Hyun-Jin Kim, Hye Jeong Yang, Myung-Sunny Kim, Dae Young Kwon, Jae-Ho Park. Citrus-derived auraptene stimulates angiogenesis by activating the Erk- and PI3K/Akt/eNOS-dependent signaling pathways in human umbilical vein endothelial cells. Journal of Functional Foods. 4: 899-905, 2012.
5.Shuaiyu Wang, Yeo Cho Yoon, Mi-Jeong Sung, Haeng-Jeon Hur, Jae-Ho Park. Antiangiogenic properties of cafestol, a coffee diterpene,in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications. 421(3): 567-571, 2012.
6.Shuaiyu Wang, Mi-Jeong Sung, Jin-Taek Hwang, Haeng-Jeon Hur, Hyun-Jin Kim, Hye Jeong Yang, Myung-Sunny Kim, Dae Young Kwon, Jae-Ho Park. Biochanin A inhibits vascular endothelial growth factor-mediated angiogenesis of human umbilical vascular endothelial cells through regulation of endothelial nitric oxide synthase and serine/threonine protein kinase-Akt. Current topics in nutraceutical research. 9(3): 99-104, 2011.